These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 24728929

  • 1. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration.
    Edwards SS, Zavala G, Prieto CP, Elliott M, Martínez S, Egaña JT, Bono MR, Palma V.
    Angiogenesis; 2014 Oct; 17(4):851-66. PubMed ID: 24728929
    [Abstract] [Full Text] [Related]

  • 2. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC).
    Zavala G, Prieto CP, Villanueva AA, Palma V.
    Stem Cell Res Ther; 2017 Sep 29; 8(1):203. PubMed ID: 28962669
    [Abstract] [Full Text] [Related]

  • 3. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L, Schiavi J, Charif N, Leger L, Yu H, Pinzano A, Henrionnet C, Stoltz JF, Bensoussan D, Huselstein C.
    Stem Cell Res Ther; 2015 Dec 30; 6():260. PubMed ID: 26718750
    [Abstract] [Full Text] [Related]

  • 4. Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).
    Prieto CP, Ortiz MC, Villanueva A, Villarroel C, Edwards SS, Elliott M, Lattus J, Aedo S, Meza D, Lois P, Palma V.
    Stem Cell Res Ther; 2017 Feb 28; 8(1):43. PubMed ID: 28241866
    [Abstract] [Full Text] [Related]

  • 5. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.
    J Med Assoc Thai; 2013 Sep 28; 96(9):1208-17. PubMed ID: 24163998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A.
    Tissue Eng Part A; 2014 Apr 28; 20(7-8):1314-24. PubMed ID: 24279891
    [Abstract] [Full Text] [Related]

  • 9. Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing.
    Doi H, Kitajima Y, Luo L, Yan C, Tateishi S, Ono Y, Urata Y, Goto S, Mori R, Masuzaki H, Shimokawa I, Hirano A, Li TS.
    Sci Rep; 2016 Jan 05; 6():18844. PubMed ID: 26728342
    [Abstract] [Full Text] [Related]

  • 10. Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms.
    Shohara R, Yamamoto A, Takikawa S, Iwase A, Hibi H, Kikkawa F, Ueda M.
    Cytotherapy; 2012 Nov 05; 14(10):1171-81. PubMed ID: 22900957
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Repair and regeneration of skin injury by transplanting microparticles mixed with Wharton's jelly and MSCs from the human umbilical cord.
    Zhang Y, Hao H, Liu J, Fu X, Han W.
    Int J Low Extrem Wounds; 2012 Dec 05; 11(4):264-70. PubMed ID: 23089966
    [Abstract] [Full Text] [Related]

  • 14. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
    Zhang L, Zhao YH, Guan Z, Ye JS, de Isla N, Stoltz JF.
    Biomed Mater Eng; 2015 Dec 05; 25(1 Suppl):137-43. PubMed ID: 25538064
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
    Reppel L, Margossian T, Yaghi L, Moreau P, Mercier N, Leger L, Hupont S, Stoltz JF, Bensoussan D, Huselstein C.
    Curr Stem Cell Res Ther; 2014 Dec 05; 9(4):306-18. PubMed ID: 24524785
    [Abstract] [Full Text] [Related]

  • 17. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K, Lech W, Figiel-Dabrowska A, Zychowicz M, Mikula M, Sarnowska A, Domanska-Janik K.
    Cytotherapy; 2016 Apr 05; 18(4):497-509. PubMed ID: 26971678
    [Abstract] [Full Text] [Related]

  • 18. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW.
    Stem Cells Dev; 2010 Dec 05; 19(12):1895-910. PubMed ID: 20367285
    [Abstract] [Full Text] [Related]

  • 19. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
    Raicevic G, Najar M, Pieters K, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.
    Tissue Eng Part A; 2012 Jul 05; 18(13-14):1410-8. PubMed ID: 22429150
    [Abstract] [Full Text] [Related]

  • 20. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.
    Regen Med; 2014 Jul 05; 9(6):723-32. PubMed ID: 25431909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.